(19)
(11) EP 4 816 536 A2

(12)

(88) Date of publication A3:
10.07.2025

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24834132.3

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
A61K 31/713(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 2310/14; A61K 31/713; C12N 2320/11; C12N 2310/315; C12N 2310/351; C12N 2320/32; C12N 15/1137; C12Y 304/21007
 
C-Sets:
  1. C12N 2310/321, C12N 2310/3521;
  2. C12N 2310/322, C12N 2310/3533;

(86) International application number:
PCT/US2024/057703
(87) International publication number:
WO 2025/117709 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 WO PCT/CN2023/135082

(71) Applicant: Sanegene Bio USA Inc.
Woburn, Massachusetts 01801 (US)

(72) Inventors:
  • ZHOU, Chunxue
    Suzhou, Jiangsu 215103 (CN)
  • ZHANG, Chunyang
    Woburn, Massachusetts 01801 (US)
  • WANG, Shiyu
    Woburn, Massachusetts 01801 (US)
  • WANG, Weimin
    Woburn, Massachusetts 01801 (US)

(74) Representative: Barrow, Nicholas Martin 
Venner Shipley LLP 406 Cambridge Science Park Milton Road
Cambridge CB4 0WW
Cambridge CB4 0WW (GB)

   


(54) SMALL INTERFERING RNA TARGETING LP(A) AND USES THEREOF